✦ LIBER ✦

High-dose 13.3mg/24h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use

✍ Scribed by Molinuevo, J.L.; Cummings, J.; Frölich, L.; Galvin, J.; Krahnke, T.; Strohmaier, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of high-dose 13.3mg/

✍ Grossberg, G.; Farlow, M.; Meng, X.; Somogyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy, safety and tolerability of a h

✍ Grossberg, George; Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Dose effects associated with rivastigmin

✍ G. T. Grossberg; J. T. Olin; M. Somogyi; X. Meng 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Effect of body mass index on the efficac

✍ Sadowsky, Carl; Somogyi, Monique; Frolich, Lutz; Meng, Xiangyi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Long-term safety and efficacy of 13.3mg/

✍ Farlow, M.; Grossberg, G.; Sadowsky, C.; Meng, X.; Somgyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Predictors of response to the 13.3 and 9

✍ Molinuevo, J.L.; Grossberg, G.; Frölich, L.; Galvin, J.; Krahnke, T.; Strohmaier 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB